Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Reviews/Commentaries/Position Statements

Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes

Bring on the heavy weights

  1. Karen A. Willey, RN1 and
  2. Maria A. Fiatarone Singh, MD, FRACP123
  1. 1School of Exercise and Sport Science, the University of Sydney, Lidcombe, Australia
  2. 2Research and Training Institute, Hebrew Rehabilitation Center for Aged, Roslindale, Massachusetts
  3. 3Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts
    Diabetes Care 2003 May; 26(5): 1580-1588. https://doi.org/10.2337/diacare.26.5.1580
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Bring on the heavy weights

    Abstract

    Exercise improves insulin resistance and has beneficial effects in preventing and treating type 2 diabetes. However, aerobic exercise is hindered in many type 2 diabetic patients because of advancing age, obesity, and other comorbid conditions. Weight lifting or progressive resistance training (PRT) offers a safe and effective exercise alternative for these people. PRT promotes favorable energy balance and reduced visceral fat deposition through enhanced basal metabolism and activity levels while counteracting age- and disease-related muscle wasting. PRT improves insulin sensitivity and glycemic control; increases muscle mass, strength, and endurance; and has positive effects on bone density, osteoarthritic symptoms, mobility impairment, self-efficacy, hypertension, and lipid profiles. PRT also alleviates symptoms of anxiety, depression, and insomnia in individuals with clinical depression and improves exercise tolerance in individuals with cardiac ischemic disease and congestive heart failure; all of these aspects are relevant to the care of diabetic elders. Moreover, PRT is safe and well accepted in many complex patient populations, including very frail elderly individuals and those with cardiovascular disease. The greater feasibility of using PRT over aerobic exercise in elderly obese type 2 diabetic individuals because of concomitant cardiovascular, arthritic, and other disease provides a solid rationale for investigating the global benefits of PRT in the management of diabetes.

    • 1RM, one repetition maximum
    • ADA, American Diabetes Association
    • BP, blood pressure
    • CWT, circuit-type weight training
    • HR, heart rate
    • IGT, impaired glucose tolerance
    • IOP, intraocular pressure
    • PRT, progressive resistance training
    • RPP, rate-pressure product

    ADVANCING AGE AND TYPE 2 DIABETES

    The value of tight blood glucose control in type 2 diabetes has been convincingly demonstrated in the U.K. Prospective Diabetes Study, among other studies. Improvement in glycemic control per se, irrespective of the means of attaining this, is the critical factor in reducing the risk of chronic diabetic complications (1). Gaining and maintaining good glycemic control hinges on enhancing insulin availability or secretion and overcoming insulin resistance. Unfortunately, advancing age, central obesity, and physical inactivity hinder medical management and may hasten development of chronic complications, particularly in elderly people who may have lived with diabetes for decades. Even when glycemic control is near optimal with medication, reducing insulin resistance by any other means must be explored in view of these adverse consequences (1).

    Because skeletal muscle is the biggest reservoir for glucose disposal (2), muscle wasting from aging and inactivity exacerbate problems of peripheral glucose uptake. Muscle weakness, decreased muscle mass, decreased activation of glycogen synthase, and changes in type IIb skeletal muscle fiber numbers are related to and may precede insulin resistance, glucose intolerance, and type 2 diabetes (3–5). Visceral fat deposition in older adults may be causally related to elevated cortisol secretion in response to stressors (6). Thus, decreased muscle mass, increased visceral adiposity, and the typical decline in physical activity with age compound insulin resistance. Moreover, individuals with diabetes have less muscular strength than age-matched counterparts, possibly due to peripheral neuropathy and reduced vascular supply (5), compounding the muscle atrophy and weakness of age and further compromising insulin sensitivity and glycemic control.

    CONVENTIONAL LIFESTYLE WEAPONS TO TARGET INSULIN RESISTANCE IN TYPE 2 DIABETES

    Dietary modification to induce weight loss is central to management of obese people with type 2 diabetes (5,7). However, the long-term difficulty of reducing total daily energy intake is well documented (8). Energy restriction as the sole means of improving glycemic control is only modest in its effect (9) because of the progressive nature of type 2 diabetes and must usually be augmented by medication (1). Conventional energy restriction recommendations are often perceived as negative, difficult, or even impossible to maintain (8), particularly in elderly people where a change to eating habits established over a lifetime may be onerous, complicated, expensive, and frightening. Weight cycling after repetitive unsuccessful attempts at weight loss by dieting can lead to lean tissue loss and decreased metabolic rate, worsening the energy balance equation (10). Dietary modification in isolation is rarely effective in sustaining long-term weight loss and consequent improvements in insulin sensitivity.

    In view of its general and diabetes-specific health benefits, detailed guidelines for exercise in type 2 diabetes have been developed by internationally reputed organizations (5,7). Unfortunately, many clinicians and patients still see exercise as a means to enhance weight loss and that improvements in insulin and glucose dynamics occur solely as a function of this. This misconception persists despite solid evidence that exercise alone, in the absence of any change in body weight or composition, is able to significantly enhance insulin sensitivity and glucose homeostasis (11,12). Exercise directly targets the metabolic derangements of diabetes compared with many medications that primarily increase available insulin supply. Moreover, most medications can only be used once fasting glucose levels rise and may produce hypoglycemia if used in patients with very mild diabetes or in the elderly, whereas exercise is appropriate long before overt hyperglycemia develops. Exercise can reduce the need for medication as well as improve cardiovascular risk factors such as hypertension, dyslipidemia, and elevated fibrinolytic activity (5).

    AEROBIC EXERCISE AND TYPE 2 DIABETES

    Aerobic exercise enhances insulin sensitivity acutely (13) and with chronic training (14–16) in type 2 diabetes. This is due to adaptive changes in skeletal muscle including increased GLUT4 transporter proteins on muscle fibers (17), increased muscle glycogen storage (18), and the cumulative effects of acute exercise bouts (5,13). This finding suggests that exercise enhances insulin sensitivity and glycemic control by changing muscle metabolism, not merely by promoting body composition change (11,12).

    Chronic aerobic training induces favorable changes in weight, body composition (10), and cortisol response to stress (19). In obese adults, it increases adherence to a hypocaloric diet (10), and when coupled with a weight-reduction diet, enhances insulin sensitivity more than dieting alone (20). Although the mechanism is not fully understood, exercise also promotes long-term weight loss and is the best predictor of long-term weight control (21). Moreover, exercise preferentially mobilizes visceral adipose tissue (22), reducing insulin resistance.

    Aerobic exercise and the prevention of type 2 diabetes

    Increased physical activity plays a substantial role in prevention of type 2 diabetes. Two large studies found a strong dose-response relationship between exercise and relative risk of developing type 2 diabetes in healthy adults. Each incremental increase in volume or intensity of physical activity decreased relative risk of developing type 2 diabetes, with the protective effect persisting even after adjustment for BMI (23,24). Physical activity unequivocally reduces the risk of developing type 2 diabetes in individuals with impaired glucose tolerance (IGT) (12,25,26). In the Da Qing IGT and the Finnish Diabetes Prevention Studies, cumulative incidence of diabetes was 20% lower with exercise (equating to 20–30 min of daily physical activity) when compared with control subjects (12,25). The U.S. Diabetes Prevention Program found that the cumulative incidence of diabetes was 58% lower in individuals treated with intensive diet and exercise than with placebo. Moreover, overall diabetes incidence was 39% lower with intensive lifestyle intervention than with metformin therapy, and this effect was enhanced with age (26).

    These findings validate the potency of small amounts of daily exercise in preventing diabetes. Exercise alone, at the relatively conservative amount of 4 h each week, is enough to substantially reduce the risk of developing diabetes (12).

    Aerobic exercise as treatment for type 2 diabetes

    Intervention studies have demonstrated that many positive effects on insulin sensitivity and glucose homeostasis occur after aerobic exercise. Acutely, a single bout of exercise can increase the glucose disposal rate (13), and chronic training, even without changes in body composition, leads to improvement in insulin sensitivity of up to 30% in individuals with IGT (14) and type 2 diabetes (14,15). Significant improvements in glycemic control have been seen after as little as 10 weeks of walking for 60 min three times weekly (15,16). Unfortunately, the applicability of many of these studies to the wider diabetic population is limited by small sample sizes, restriction of subjects to those without comorbid disease, short training duration, and poor study designs that lack proper randomization procedures or control groups.

    However, a meta-analysis of 14 randomized controlled trials of at least 8 weeks’ duration, comparing an exercise intervention with a concurrent nonexercising control group in adults with type 2 diabetes, found that the 528 subjects had a mean fall in HbA1c of 0.74% (P = 0.00003) after exercise and this fall was not related to body weight change (11). This finding supports the concept that exercise alone, in the absence of body composition change, is able to enhance glucose homeostasis (11,12).

    Feasibility of aerobic exercise in older obese people with type 2 diabetes

    Because of the interaction of age-related changes and pathophysiology of diabetes and other diseases, the potential benefits of physical activity for elderly obese people with diabetes are enormous. However, translation of aerobic exercise recommendations (5,7) into appropriate activity regimens for these individuals is challenging and often impossible to implement. Even walking may be difficult or risky because of clustering of conditions such as arthritis, cardiovascular disease, peripheral vascular disease, neuropathy, and mobility impairment. When other common problems including hypertension, sleep apnea, low self-efficacy, poor self-esteem, and depression are added into the equation, they compound the large personal and economic cost of diabetes, impede compliance with treatment goals, and reduce quality of life.

    PROGRESSIVE RESISTANCE TRAINING: A NEW STRATEGY FOR FIGHTING INSULIN RESISTANCE

    Weight lifting or progressive resistance training (PRT) is now advocated as an important part of exercise for general fitness and well-being (27). It is recommended by the American College of Sports Medicine for the elderly (28) and the obese (10), in secondary prevention of coronary heart disease (29) and in type 2 diabetes (5). Its use in diabetes is supported by the American Diabetes Association (ADA), although not in older individuals or individuals with long-standing diabetes (7), but the reasons given for this are vague and not supported by scientific justification (Table 1). There is also no evidence base from which the ADA draws its recommendation to limit PRT to light weights and high volumes of repetitions for the upper body. Thus, conflicting opinions offered in these guidelines indicate the need for a better understanding of the risks and benefits of PRT in type 2 diabetes.

    PRT is defined as exercise in which the resistance against which a muscle generates force is progressively increased over time (28). It increases muscular size and strength, changes body composition by increasing lean body mass and decreasing visceral and total body fat (30), and leads to changes in neuroendocrine and cardiovascular function (31). These adaptations are a function of the intensity and volume (sets × repetitions × load) of the exercise (31). Resistance training at intensities between 60 and 100% of the maximal capacity (the one repetition maximum [1RM]) elicit structural, functional, and metabolic changes in skeletal muscle, with higher intensities leading to greater adaptation (32).

    PRT has potential roles in athletic conditioning, in rehabilitation, in counteracting age- and disease-related muscle wasting, and in maintaining health and preventing disease (32). Reductions in visceral adiposity occur in older adults after PRT, even when changes in total body fat and weight are small (30). Habitual adaptation to PRT lowers the cortisol response to acute stress (19), increases total energy expenditure and physical activity in healthy (33) and frail older adults (34), and relieves anxiety, depression, and insomnia in clinical depression (35). It has positive effects on bone density (33), osteoarthritic symptoms (32,36), mobility impairment (34,37), self-efficacy (38), hypertension (39), lipid profiles (40,41), and exercise tolerance in cardiac ischemic disease (42) and congestive heart failure (43); all of these aspects are relevant in the care of older obese patients with diabetes.

    PRT and the prevention of type 2 diabetes

    There are little data available on the role of PRT in preventing type 2 diabetes. Given its mechanism of action, PRT could potentially play a significant role, but this warrants further investigation. Its role in preventing type 2 diabetes in individuals with IGT was demonstrated with the inclusion of supervised, progressive, circuit-type weight training (CWT) as part of the intensive lifestyle intervention in the Finnish Diabetes Prevention Study. The degree to which PRT contributed to the reduced risk of diabetes after lifestyle intervention is difficult to quantify but cannot be discounted. This is because the participation rate in supervised CWT sessions in the first year of the study was up to 85%, and no less than 50%, depending on the study center (12). If relative risk for diabetes is reduced by CWT (moderate intensity PRT of ∼50% 1RM), then PRT of higher intensities (60–100% 1RM), which elicits greater structural, functional, and metabolic changes in skeletal muscle than CWT, could have an equivalent, if not greater, effect. This hypothesis is yet to be tested.

    PRT as treatment for type 2 diabetes

    Of relevance to the treatment of type 2 diabetes are the effects of PRT on insulin action, lipid metabolism, and glucose metabolism. PRT has been shown to improve glucose disposal rates, increase glycogen storage capacity, increase GLUT4 receptors on skeletal muscle, and improve insulin sensitivity and glucose tolerance in normal (44–46) and clinical populations (45,47–51). A single bout of resistance exercise lowered total insulin response to an oral glucose tolerance test in seven subjects with type 2 diabetes (45). Insulin sensitivity improved by 48% in nine subjects with type 2 diabetes after 4–6 weeks of moderate-intensity (40–50% 1RM) resistance training and occurred despite no change in body composition (48).

    Effects of PRT on lipid metabolism are equivocal. However, there is some evidence that it increases HDL cholesterol levels in normal subjects (40,52) and lowers triglyceride and LDL cholesterol levels in type 2 diabetic subjects (41).

    Improvements in glycemic control have also been demonstrated after PRT (47–51,53). However, only three randomized controlled trials have examined long-term effects of PRT on glycemic control in older diabetic adults (Table 2). Six months of high-intensity PRT (75–80% 1RM) combined with moderate energy restriction in 29 older overweight sedentary subjects with type 2 diabetes induced a significant reduction in HbA1c from baseline (−1.21 ± 0.2%) compared with no change in diet alone and control groups. These findings remained significant after adjustment for fat mass (49). In another study of 43 older Hispanic subjects with type 2 diabetes, 16 weeks of high-intensity PRT significantly improved HbA1c when compared with a nonexercising control group (−1.0 ± 1.1 vs. 0.4 ± 1.2%, respectively; P = 0.0001). Significant falls in fasting insulin levels and waist circumference as well as significant increases in muscle glycogen content and mean muscle strength were also noted after PRT when compared with control subjects (50). Even 8 weeks of CWT in 27 subjects with type 2 diabetes induced significant reductions in glucose and insulin areas under the curve relative to nonexercising control subjects (51).

    Interpretation of available data on the effects of PRT on insulin sensitivity and glucose homeostasis in type 2 diabetes must be tempered in some cases by small sample sizes, uncontrolled study designs, inconsistent measurement of insulin action, short durations, and variable intensity of training used. Even though these data are not analogous, the magnitude of improvement in insulin sensitivity and glycemic control appears to be a function of PRT intensity. Small changes to these parameters have been noted even with CWT (41,51,53,54), and moderate to high intensities of PRT (60–90% 1RM) produced a more potent stimulus for change than aerobic training, given the results of the best-designed studies described above (45,47,48). Aerobic exercise does not have the same potential as PRT to increase muscle mass and is thus unlikely to provide benefit via this mechanism of action (Table 3).

    Safety and feasibility of PRT in older obese people with type 2 diabetes

    Detailed guidelines for safe, effective, and appropriate PRT regimens for elderly people with type 2 diabetes are well documented (5,32). However, PRT is not routinely used in the clinical management of diabetes, despite recommendations for this in recent position statements from the ADA (7) and the American College of Sports Medicine (5). In the past, PRT has been viewed as an inherently risky form of exercise and is still deliberately avoided by many clinicians in their physical activity recommendations to older adults and those with diseases such as diabetes, hypertension, and cardiovascular disease. A wealth of data demonstrates that PRT is indeed safe, effective, well accepted, and potentially more feasible than aerobic exercise in many complex patient groups including the elderly and individuals with disability or disease (32,34,42,43). Moreover, PRT is preferential to aerobic training in patients with some clinical scenarios common in older diabetic individuals, including foot ulceration or Charcot’s joint, lower-extremity amputation without prosthesis, severe osteoarthritis, angina, and/or claudication, and in individuals at high risk of falling (32).

    Feasibility and acceptability of supervised PRT to older people with type 2 diabetes is suggested by compliance rates of 90–100% documented in two of the three randomized controlled trials described above (49,50). Other compliance rates for PRT of 4 weeks to 6 months’ duration are reported as 83–96% in subjects aged 65–98 years (34,55) including independent individuals (55) and very frail nursing home residents (34). Furthermore, no exercise-related injuries or complications were reported, attesting to the safety of supervised PRT in elderly clinical populations.

    Medical contraindications to PRT are relatively few and are outlined in Table 4. Musculoskeletal injury is mostly preventable with proper technique, isolation of the targeted muscle group, and slow lifting speed without momentum or ballistic movements. Machines or chairs with good back support should be used with range of motion limited to the pain-free arc and rest periods between sets and sessions strictly observed (32) (Table 5). Acute injury is usually sharp localized pain felt during or immediately after training and should be treated immediately with rest, ice, compression, and elevation of the affected area. Acute injury is distinct from delayed-onset muscle soreness, which requires no treatment, is a normal response to initiation or increase in training intensity, and is due to muscle ultrastructure damage during loading, which causes an inflammatory response. Repair of this damage leads to desirable adaptations of increased protein synthesis and muscle fiber hypertrophy (31,32).

    Cardiovascular Response to PRT

    Cardiovascular responses to PRT remain an area of concern for many clinicians. Studies show large brief pulsatile swings in arterial blood pressure (BP) throughout each repetition at high intensities (56) and an associated increase in heart rate (HR). Peak arterial BP rises over a set of repetitions, with HR and BP response proportional to the load lifted. However, these effects are transient, returning to baseline values or below within 1–2 s after the final lift (57). Moreover, chronic PRT reduces acute systolic BP, diastolic BP, and rate-pressure product (RPP) responses to weight lifting by 17–27% (57).

    Climbing 12 flights of stairs produced greater systolic BP, HR, and RPP responses in 17 older healthy men (mean age 64 years) than weight lifting. Stair climbing RPP was 50% greater than weight lifting RPP, suggesting greater myocardial oxygen demand. A total of 10–12 repetitions at 70–80% 1RM elicited higher systolic BP, diastolic BP, and lower HR responses than incline walking but similar RPP values, suggesting comparable myocardial oxygen demand (58). However, the higher diastolic pressure with PRT ensures a more prolonged coronary artery filling at a higher perfusion pressure than aerobic exercise (57), which is of potential benefit to older individuals, particularly those with diastolic dysfunction or coronary artery disease. Consistent with this are reports of patients who exhibit ischemia or angina during treadmill work but not during PRT at similar elevations of RPP (57). Additionally, ischemic signs and symptoms are reduced after PRT in cardiac patients, attesting to its safety even in high-risk individuals (42,58,59), with no clinically significant nonfatal or fatal cardiovascular events reported in over 26,000 maximal strength tests performed (60). These studies support the safety of PRT in older adults, including those with coronary artery disease, suggesting that PRT may be preferable to aerobic training in many clinical population groups.

    Precautions for use of PRT in older obese people with type 2 diabetes

    Before prescribing any physical activity regimen, patients should be assessed for metabolic control, complications status, and any other medical contraindications to exercise. Detailed guidelines for comprehensive preactivity assessment are well documented (5).

    Cardiovascular disease

    In individuals with cardiovascular disease, PRT is well-tolerated and complementary to an aerobic training regimen (42,43). In some cases, PRT may even be preferable to an aerobic exercise regimen because of its lower HR and RPP response. Given the increased risk of cardiovascular mortality in older diabetic subjects, even without coronary history, a graded cardiovascular stress test measuring HR, BP, and 12-lead electrocardiogram response is advisable for individuals with clinical markers or significant risk factors for coronary artery disease. Such testing may not directly predict cardiovascular responses to PRT but would identify individuals with exercise contraindications, including marked ischemia, severe arrhythmias, or an exaggerated hypertensive response to exercise (5,7) (Table 4).

    Peripheral vascular disease and neuropathy

    In individuals with lower-limb complications, including foot ulceration, Charcot’s joint, severe peripheral vascular disease, and osteoarthritis, conventional forms of exercise may be hindered. A well-supervised PRT regimen could offer an effective alternative in these individuals. The risk of foot injury from the repetitive load-bearing on lower limbs associated with walking or other aerobic activities is likely to be far greater than that seen with PRT using a variety of weight machines targeting different muscle groups. The use of good footwear and routine pre- and postexercise preventative foot examination would reduce this risk further. Many PRT exercises can be performed seated in chairs with no pressure on the feet. Weight lifting is also an option for individuals with recent lower-extremity amputation, individuals awaiting peripheral bypass surgery, or when foot ulcers preclude weight-bearing exercise. Maintenance of upper- and lower-body strength will optimize recovery from surgery; transfer capability, functional independence, and adaptation to a prosthesis; or minimize debilitation from periods of bed or wheelchair confinement related to these conditions. Clinicians often wrongly assume that if aerobic exercise or walking cannot take place, then exercise must be abandoned. The potential role for PRT in just such situations is obvious and vastly underused.

    Nephropathy

    The rise in BP associated with PRT implies caution in individuals with nephropathy, but there is no evidence that exercise-induced BP changes exacerbate its progression (5). However, in the absence of definitive data, individuals with nephropathy may want to avoid activities that cause systolic BP elevation more than 200 mmHg, because this could potentially worsen the progression of disease (5). PRT has other benefits in individuals with renal disease. A recent study evaluated 12 weeks of high-intensity PRT in 26 older subjects with moderate renal insufficiency, 10 of whom had type 2 diabetes as the underlying cause. All were consuming a low-protein diet to slow progression of renal failure. In individuals randomized to PRT, there was significant improvement in muscle mass, nutritional status, and functional capacity compared with individuals on a low-protein diet alone. PRT offset the wasting syndrome of uremia without adverse events or injuries. Moreover, urinary creatinine excretion decreased by 8% and glomerular filtration rate improved significantly compared with diet alone, suggesting that PRT does not cause short-term renal function deterioration (61).

    Retinopathy

    Exercise increases systemic and retinal BP (5), but there is no evidence that it accelerates diabetic retinopathy either acutely or with chronic training (62). In a study of diabetic subjects with proliferative retinopathy, subjects trained aerobically at increasing intensities until BP reached 50 mmHg over baseline levels or a maximum of 200 mmHg. No new retinal hemorrhages occurred in any subjects (63), suggesting that low-intensity training is safe for individuals with retinopathy as long as systolic BP is maintained below 200 mmHg (5). Changes in intraocular pressure (IOP) secondary to Valsalva maneuvers may be more critical than changes in systemic BP on retinal hemorrhage risk. IOP rose markedly during maximal isometric contraction in power-lifters (64), but pressure changes were transient, lasting 3–8 s (65), questioning whether short intermittent rises in IOP cause long-term sequelae. Chronic aerobic training reduces IOP (66), but it is unknown whether chronic PRT has similar effects. A large study of 606 people with type 1 diabetes followed over 6 years found no association between self-reported level of physical activity and progression or development of proliferative retinopathy. No association was found even in individuals who undertook PRT (67). No similar studies have been performed in older subjects with type 2 diabetes. Given the available data, older subjects with type 2 diabetes who do not have diabetic retinopathy, or have mild to moderate stable nonproliferative retinopathy, could safely undertake PRT as long as care is taken to avoid Valsalva maneuvers and BP is monitored regularly. Until evidence is provided to the contrary, individuals with severe proliferative retinopathy should avoid any activity that may increase IOP, including near-maximal isometric contractions or Valsalva maneuvers (62). There are no data to indicate when PRT may be resumed after cataract, laser, or glaucoma surgery, but most ophthalmologists recommend restriction of such activities for 1–2 months postoperatively.

    SUMMARY

    Despite the growing knowledge base supporting the use of PRT in insulin resistance and complex patient populations and its inclusion in physical activity guidelines by international expert committees (5,7), it is not routinely part of usual care for type 2 diabetes. Exploration of the benefits of PRT in diabetes, the mechanisms underlying its effect on insulin resistance, and its acceptability to patients and clinicians should be the basis for further research. The social and financial costs of caring for older obese diabetic individuals are substantial. Including PRT in their treatment regimen, if successful, should improve physiological and psychological function, change body composition, and improve glucose homeostasis, resulting in improved quality of life. The greater feasibility of using PRT over aerobic exercise in this population because of concomitant cardiovascular, arthritic, and other disease provides a solid rationale for further investigation into the global benefits of PRT in the clinical management of older diabetic subjects.

    View this table:
    • View inline
    • View popup
    Table 1—

    Recommendations for use of PRT in clinical populations

    View this table:
    • View inline
    • View popup
    Table 2—

    Randomized controlled trials examining the effects of PRT in type 2 diabetes

    View this table:
    • View inline
    • View popup
    Table 3—

    Exercise modality, body composition, and glucose homeostasis

    View this table:
    • View inline
    • View popup
    Table 4—

    Medical contraindications to PRT

    View this table:
    • View inline
    • View popup
    Table 5—

    Recommendations for safe and effective PRT in type 2 diabetes

    Footnotes

    • Address correspondence and reprint requests to Prof. Maria A. Fiatarone Singh, School of Exercise and Sport Science, the University of Sydney, PO Box 170, Lidcombe, NSW, 1285 Australia. E-mail: m.singh{at}fhs.usyd.edu.au.

      Received for publication 7 November 2002 and accepted in revised form 16 January 2003.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • DIABETES CARE

    References

    1. ↵
      Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      De Fronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000–1007, 1981
      OpenUrlAbstract/FREE Full Text
    3. ↵
      Vaag A, Henriksen JE, Beck-Neilsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782–788, 1992
    4. Nyholm B, Qu Z, Kaal A, Pedersen SB, Gravholt CH, Andersen JL, Saltin B, Schmitz O: Evidence of an increased number of type 2b muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 46:1822–1828, 1997
      OpenUrlAbstract/FREE Full Text
    5. ↵
      Albright A, Franz M, Hornsby G, Kriska A, Marrero D, Ullrich I, Verity LS: American College of Sports Medicine position stand: exercise and type 2 diabetes. Med Sci Sports Exerc 32:1345–1360, 2000
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      Epel E, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell K, Bell J, Ickovics JR: Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med 62:623–632, 2000
      OpenUrlAbstract/FREE Full Text
    7. ↵
      American Diabetes Association: Diabetes mellitus and exercise (Position Statement). Diabetes Care 24 (Suppl. 1):S51–S55, 2001
      OpenUrlCrossRef
    8. ↵
      Eeley EA, Stratton IM, Hadden DR, Turner RC, Holman RR: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy: UKPDS 18. Diabet Med 13:656–662, 1996
      OpenUrlCrossRefPubMedWeb of Science
    9. ↵
      Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D: Long-term effects of modest weight loss in type 2 diabetic patients. Arch Intern Med 147:1749–1753, 1987
      OpenUrlCrossRefPubMedWeb of Science
    10. ↵
      American College of Sports Medicine: Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 33:2145–2156, 2001
      OpenUrlPubMedWeb of Science
    11. ↵
      Boule N, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218–1227, 2001
      OpenUrlCrossRefPubMedWeb of Science
    12. ↵
      Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Saliminen V, Uusitupa M, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V: Prevention of type 2 diabetes by changes in lifestyle among dubjects with impaired glucose tolerance. N Engl J Med 344:1343–1350, 2001
      OpenUrlCrossRefPubMedWeb of Science
    13. ↵
      Rogers MA: Acute effects of exercise on glucose tolerance in non-insulin-dependent diabetes. Med Sci Sports Exerc 21:362–368, 1989
      OpenUrlPubMed
    14. ↵
      Bogardus C, Ravussin E, Robbins DC, Wolfe RR, Horton ES, Sims EAH: Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 33:311–318, 1984
      OpenUrlAbstract/FREE Full Text
    15. ↵
      Trovati M, Carta Q, Cavalot F, Vitali S, Banaudi C, Lucchina PG, Fiocchi F, Emanuelli G, Lenti G: Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7:416–420, 1984
      OpenUrlAbstract/FREE Full Text
    16. ↵
      Walker K, Piers LS, Putt RS, Jones JA, O’Dea K: Effects of regular walking on cardiovascular risk factors and body composition in normoglycaemic women and women with type 2 diabetes. Diabetes Care 22:555–561, 1999
      OpenUrlAbstract
    17. ↵
      Dela F, Ploug T, Handberg A, Petersen LN, Larsen JL, Mikines KJ, Galbo H: Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 43:862–865, 1994
      OpenUrlAbstract/FREE Full Text
    18. ↵
      Hickner R, Fisher JS, Hansen PA, Racette SB, Mier CM, Turner MJ, Holloszy JO: Muscle glycogen accumulation after endurance exercise in trained and untrained individuals. J Appl Physiol 83:897–903, 1997
      OpenUrlAbstract/FREE Full Text
    19. ↵
      Fabbri A, Giannini D, Aversa A, DeMartino MU, Fabbrini E, Fraceschi F, Moretti C, Frajese G, Isidori A: Body-fat distribution and responsiveness of the pituitary-adrenal axis to corticotropin-releasing-hormone stimulation in sedentary and exercising women. J Endocrinol Invest 22:377–385, 1999
      OpenUrlPubMed
    20. ↵
      Rice B, Janssen I, Hudson R, Ross R: Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care 22:684–691, 1999
      OpenUrlAbstract/FREE Full Text
    21. ↵
      Long BC: Stress-management interventions: a 15-month follow-up of aerobic conditioning and stress inoculation training. Cognit Ther Res 9:471–478, 1985
      OpenUrl
    22. ↵
      Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP, Duvallet A, Guezennec CY, Cathelineau G: Mobilization of visceral adipose tissue related to the improvements in insulin sensitivity in response to physical training in NIDDM: effects of branched-chain amino acid supplements. Diabetes Care 20:385–391, 1997
      OpenUrlAbstract/FREE Full Text
    23. ↵
      Helmrich SP, Ragland DR, Leung RW, Paffenberger RS Jr: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147–152, 1991
      OpenUrlCrossRefPubMedWeb of Science
    24. ↵
      Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC, Speizer FE, Manson JE: Walking compared with vigorous physical activity and risk of type 2 diabetes in women. JAMA 282:1433–1439, 1999
      OpenUrlCrossRefPubMedWeb of Science
    25. ↵
      Pan X-R, Li G-W, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, Hu Z-X, Lin J-L, Xiao J-Z, Cao H-B, Liu P-A, Jiang X-G, Jiang Y-Y, Wang J-P, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544, 1997
      OpenUrlAbstract/FREE Full Text
    26. ↵
      Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002
      OpenUrlCrossRefPubMedWeb of Science
    27. ↵
      American College of Sports Medicine: The Recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults (Position Stand). Med Sci Sports Exerc 30:975–991, 1998
      OpenUrlCrossRefPubMedWeb of Science
    28. ↵
      American College of Sports Medicine: Exercise and physical activity for older adults (Position Stand). Med Sci Sports Exerc 30:992–1008, 1998
      OpenUrlCrossRefPubMedWeb of Science
    29. ↵
      Ades P: Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345:892–902, 2001
      OpenUrlCrossRefPubMedWeb of Science
    30. ↵
      Treuth M, Hunter GR, Kekes-Szabo T, Weinsier RL, Goran MI, Berland L: Reduction in intra-abdominal adipose tissue after strength training in older women. J Appl Physiol 78:1425–1431, 1995
      OpenUrlAbstract/FREE Full Text
    31. ↵
      Kraemer W, Deschenes M, Fleck S: Physiological adaptations to resistance exercise: implications for athletic conditioning. Sports Med 6:246–256, 1988
      OpenUrlPubMedWeb of Science
    32. ↵
      Fiatarone Singh MA: The exercise prescription. In Exercise, Nutrition, and the Older Woman: Wellness for Women Over Fifty. Fiatarone Singh MA, Ed. Boca Raton, FL, CRC Press, 2000, p. 37–104
    33. ↵
      Nelson ME, Fiatarone MA, Marganti CM, Trice I, Greenberg RA, Evans WJ: Effects of high intensity strength training on multiple risk factors for osteoporotic fractures. JAMA 272:909–1914, 1994
      OpenUrlCrossRefPubMed
    34. ↵
      Fiatarone M, O’Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ: Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330:1769–1775, 1994
      OpenUrlCrossRefPubMedWeb of Science
    35. ↵
      Singh N, Clements K, Fiatarone M: A randomized controlled trial of progressive resistance training in depressed elders. J Gerontol A Biol Sci Med Sci 52:M27–M35, 1997
      OpenUrl
    36. ↵
      Ettinger WJ Jr, Burns R, Messier SP, Applegate W, Rejeski WJ, Morgan T, Shumaker S, Berry MJ, O’Toole M, Monu J, Craven T: A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: the Fitness Arthritis and Seniors Trial. JAMA 277:25–31, 1997
      OpenUrlCrossRefPubMedWeb of Science
    37. ↵
      Brill PA, Probst JC, Greenbouse DL, Schell B, Macera CA: Clinical feasibility of a free-weight strength-training program for older adults. J Am Board Fam Pract 11:445–451, 1998
      OpenUrlAbstract/FREE Full Text
    38. ↵
      Ewart C, Stewart KJ, Gillilan RE, Kelemen MH: Self-efficacy mediates strength gains during circuit weight training in men with coronary artery disease. Med Sci Sports Exerc 18:531–540, 1986
      OpenUrlPubMedWeb of Science
    39. ↵
      Kelley G, Kelley K: Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials. Hypertension 35:838–843, 2000
      OpenUrlAbstract/FREE Full Text
    40. ↵
      Wallace MB, Moffatt RJ, Haymes EM, Green NR: Acute effects of resistance exercise on parameters of lipoprotein metabolism. Med Sci Sports Exerc 23:199–204, 1991
      OpenUrlPubMed
    41. ↵
      Honkola A, Forsen T, Eriksson J: Resistance training improves the metabolic profile of individuals with type 2 diabetes. Acta Diabetol 34:245–248, 1997
      OpenUrlCrossRefPubMedWeb of Science
    42. ↵
      McCartney N: Role of resistance training in heart disease. Med Sci Sports Exerc 30:S396–S402, 1998
      OpenUrlPubMedWeb of Science
    43. ↵
      Pu CT, Johnson MT, Forman DE, Hausdorff JM, Roubenoff R, Foldvari M, Fielding RA, Singh MA: Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol 90:2341–1350, 2001
      OpenUrlAbstract/FREE Full Text
    44. ↵
      Miller J, Pratley RE, Goldberg AP, Gordon P, Rubin M, Treuth MS, Ryan AS, Hurley BF: Strength training increases insulin action in healthy 50- to 65-yr-old men. J Appl Physiol 77:1122–1127, 1994
      OpenUrlAbstract/FREE Full Text
    45. ↵
      Fluckey JD, Hickey MS, Brambrink JK, Hart KK, Alexander K, Craig BW: Effects of resistance exercise on glucose tolerance in normal and glucose-intolerant subjects. J Appl Physiol 77:1087–1092, 1994
      OpenUrlAbstract/FREE Full Text
    46. ↵
      Tesch P, Colliander E, Kaiser P: Muscle metabolism during intense heavy-resistance exercise. Eur J Appl Physiol Occup Physiol 55:362–366, 1986
      OpenUrlCrossRefPubMedWeb of Science
    47. ↵
      Eriksson J, Taimela S, Eriksson K, Parviainen S, Peltonen J, Kujala U: Resistance training in the treatment of non-insulin-dependent diabetes mellitus. Int J Sports Med 18:242–246, 1997
      OpenUrlCrossRefPubMedWeb of Science
    48. ↵
      Ishii T, Yamakita T, Sato T, Tanaka S, Fujii S: Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care 21:1353–1355, 1998
      OpenUrlAbstract/FREE Full Text
    49. ↵
      Dunstan DW, Daly RM, Owen N, Jolley D, deCourten M, Shaw J, Zimmet P: High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 25:1729–1736, 2002
      OpenUrlAbstract/FREE Full Text
    50. ↵
      Castaneda C, Layne JE, Munoz-Orians L, Gordon PL, Walsmith J, Foldvari M, Roubenoff R, Tucker KL, Nelson ME: A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 25:2335–2341, 2002
      OpenUrlAbstract/FREE Full Text
    51. ↵
      Dunstan DW, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG: Effects of a short-term circuit weight training program on glycaemic control in NIDDM. Diabetes Res Clin Pract 40:53–61, 1998
      OpenUrlCrossRefPubMedWeb of Science
    52. ↵
      Joseph LJ, Davey SL, Evans WJ, Campbell WW: Differential effects of resistance training on the body composition and lipoprotein-lipid profile in older men and women. Metab Clin Exp 48:1474–1480, 1999
    53. ↵
      Maiorana A, O’Driscoll G, Goodman C, Taylor R, Green D: Combined aerobic and resistance exercise improves glycemic control and fitness in type 2 diabetes. Diabetes Res Clin Pract 56:115–123, 2002
      OpenUrlCrossRefPubMedWeb of Science
    54. ↵
      Eriksson J, Tuominen J, Valle T, Sundberg S, Sovijarvi A, Lindholm H, Tuomilehto J, Koivisto V: Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance? Horm Metab Res 30:37–41, 1998
      OpenUrlCrossRefPubMedWeb of Science
    55. ↵
      Ryan AS, Hurlbut DE, Lott ME, Ivey FM, Fleg J, Hurley BF, Goldberg AP: Insulin action after resistive training in insulin resistant older men and women. J Am Geriatr Soc 49:247–253, 2001
      OpenUrlCrossRefPubMedWeb of Science
    56. ↵
      MacDougall JD, Tuxen D, Sale DG, Moroz JR, Sutton JR: Arterial blood pressure response to heavy resistance exercise. J Appl Physiol 58:785–790, 1985
      OpenUrlAbstract/FREE Full Text
    57. ↵
      McCartney N: Acute responses to resistance training and safety. Med Sci Sports Exerc 31:31–37, 1999
      OpenUrlPubMedWeb of Science
    58. ↵
      Benn S, McCartney N, McKelvie R: Circulatory responses to weight lifting, walking, and stair climbing in older males. J Am Geriatr Soc 44:121–125, 1996
      OpenUrlPubMedWeb of Science
    59. ↵
      Bertagnoli K, Hanson P, Ward A: Attenuation of exercise-induced ST depression during combined isometric and dynamic exercise in coronary artery disease. Am J Cardiol 65:314–317, 1990
      OpenUrlCrossRefPubMedWeb of Science
    60. ↵
      Gordon N, Kohl HW, Pollock ML, Vaandrager H, Gibbons LW, Blair SN: Cardiovascular safety of maximal strength testing in healthy adults. Am J Cardiol 76:851–853, 1995
      OpenUrlCrossRefPubMedWeb of Science
    61. ↵
      Castaneda C, Gordon PL, Uhlin KD, Levey AS, Kehayias JJ, Dwyer JT, Fielding RA, Roubenoff R, Fiatarone Singh MA: Resistance training to counteract the catabolism of low-protein diet in patients with chronic renal insufficiency: a randomized, controlled trial. Ann Intern Med 135:965–976, 2001
      OpenUrlCrossRefPubMedWeb of Science
    62. ↵
      Aiello LP, Cahill MT, Wong JS: Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 132:760–776, 2001
      OpenUrlCrossRefPubMedWeb of Science
    63. ↵
      Bernbaum M, Albert SG, Cohen JD, Drimmer A: Cardiovascular conditioning in individuals with diabetic retinopathy. Diabetes Care 12:740–742, 1989
      OpenUrlAbstract/FREE Full Text
    64. ↵
      Dickerman RD, Smith GH, Langham-Roof L, McConathy WJ, East JW, Smith AB: Intra-ocular pressure changes during sub-maximal isometric contraction: does this reflect intra-cranial pressure or retinal venous pressure? Neurol Res 21:243–246, 1999
      OpenUrlPubMedWeb of Science
    65. ↵
      Fleck S, Dean L: Resistance-training experience and the pressor response during resistance exercise. J Appl Physiol 63:116–120, 1987
      OpenUrlAbstract/FREE Full Text
    66. ↵
      Passo M, Goldberg L, Elliot DL, VanBuskirk EM: Regular exercise lowers intraocular pressure in glaucoma patients. Invest Ophthalmol Vis Sci 35 (Suppl.):1254, 1994
      OpenUrlPubMed
    67. ↵
      Cruickshanks KJ, Moss SE, Klein R, Klein BEK: Physical activity and the risk of progression or development of proliferative retinopathy. Ophthalmology 102:1177–1182, 1995
      OpenUrlPubMed
    68. Borg G, Linderholm H: Exercise performance and perceived exertion in patients with coronary insufficiency, arterial hypertension and vasoregulatory asthenia. Acta Med Scand 187:17–26, 1970
      OpenUrlPubMedWeb of Science
    PreviousNext
    Back to top
    Diabetes Care: 26 (5)

    In this Issue

    May 2003, 26(5)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes
    Karen A. Willey, Maria A. Fiatarone Singh
    Diabetes Care May 2003, 26 (5) 1580-1588; DOI: 10.2337/diacare.26.5.1580

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes
    Karen A. Willey, Maria A. Fiatarone Singh
    Diabetes Care May 2003, 26 (5) 1580-1588; DOI: 10.2337/diacare.26.5.1580
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • ADVANCING AGE AND TYPE 2 DIABETES
      • CONVENTIONAL LIFESTYLE WEAPONS TO TARGET INSULIN RESISTANCE IN TYPE 2 DIABETES
      • AEROBIC EXERCISE AND TYPE 2 DIABETES
      • PROGRESSIVE RESISTANCE TRAINING: A NEW STRATEGY FOR FIGHTING INSULIN RESISTANCE
      • SUMMARY
      • Footnotes
      • References
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Managing Preexisting Diabetes for Pregnancy
    • Third Annual World Congress on the Insulin Resistance Syndrome
    • Third Annual World Congress on the Insulin Resistance Syndrome
    Show more Reviews/Commentaries/Position Statements

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.